Horizon 1000 is a $50 million OpenAI–Gates Foundation initiative to scale AI tools for intake, triage and follow-up in 1,000 African clinics by 2028.
Anthropic has unveiled Claude for Healthcare and Life Sciences, a specialized AI suite powered by the new Claude Opus 4.5 model. Unlike OpenAI’s patient-focused ChatGPT Health, this offering prioritizes administrative efficiency and safety, mandating professional review for high-risk outputs while utilizing “connectors” to integrate with Medidata, CMS databases, and PubMed to automate complex workflows.
ChatGPT Health is OpenAI’s new health-focused feature, linking medical records and wellness data to support more contextual, personalized health assistance.
Delphi-2M, trained on UK and Danish datasets, predicts disease risks for 1,258 conditions up to 20 years in advance, supporting preventive healthcare planning.
Microsoft’s MAI-DxO surpassed physicians in diagnosing complex NEJM cases with 85.5% accuracy. Transparent, efficient, and scalable—AI medicine enters a new era.
AlphaGenome, DeepMind’s latest AI, simulates how mutations impact gene regulation, enabling breakthrough research in genomics, cancer, and synthetic biology.
Elsa, the FDA’s internal AI assistant, was deployed across the agency to improve efficiency. Staff say it’s rushed, flawed, and not ready for regulatory use.
Google’s TxGemma, an open AI suite for drug discovery, integrates with pediatric cancer tools like Capricorn. Despite $60B industry investment, licensing and trial challenges persist.
Microsoft’s Dragon Copilot combines AI dictation and ambient listening to streamline clinical workflows, reducing clinician burnout by 70% and saving 5 minutes per patient encounter. Built on ethical AI principles.
